Small Molecules, Biosimilars & Therapeutic Targets
Age-related macular degeneration (AMD) affects 11 million people in the U.S. It occurs when aging causes damage to the macula, the part of the eye that controls straight-ahead vision. There are two types: dry AMD and wet AMD. Dry AMD is when the macula gets thinner with age, while wet AMD occurs when abnormal blood […]
Anti-VEGFs Produce Good Outcomes
The number of people who will become visually impaired in the U.S. is expected to be 8 million. In addition to that, another 16 million will have difficulty seeing due to refractive errors such as myopia (nearsightedness) or hyperopia (farsightedness) that can be corrected with glasses or contacts. In 2015, 3.2 million Americans had vision […]